Automatic Website Traffic RSS

Arrowhead Pharmaceuticals Could Become The Next Gilead

Arrowhead Pharmaceuticals Could Become The Next Gilead Sep. 07, 2018 1:14 PM ET Arrowhead Pharmaceuticals, Inc. (ARWR) Stock ABBV , GILD , ARWR 38 Comments 10 Likes iWatchMarkets ... read more

4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout

For good reasons, Arrowhead Pharmaceuticals (ARWR 0.12%) is a prime candidate for the next big biotech buyout. Here are four of the most important ones. Image source: Getty Images. read more

Arrowhead Pharmaceuticals' SWOT analysis: stock poised for ... - MSN

Arrowhead Pharmaceuticals, Inc. ... a significant step forward for Arrowhead, as plozasiran could become the company's first ... to find out and take your investment strategy to the next level. read more

Johnson & Johnson and Arrowhead Pharmaceuticals Could Have Big News ...

The start of a Phase 3 trial could be a small to modest potential pop for JNJ on the news, but could be a lot bigger pop for Arrowhead Pharmaceuticals as a sub-$5B market cap company. read more

What's Next for Arrowhead Pharmaceuticals, Inc. After the Stock ...

Arrowhead's stock cratered after the announcement of an FDA clinical hold. Can the biotech make a comeback? S&P 500 +---% | Stock Advisor +---% Join The Motley Fool. Accessibility Log ... read more

Arrowhead Pharmaceuticals (ARWR): Among the Most Oversold Healthcare ...

We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a look at where Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) stands ... read more

Which Biotech Will Become the Next Gilead Sciences, Inc.?

When it comes to investing in the biotech sector, perhaps no company has been a better poster child for success than Gilead Sciences . Over the. read more

Here's Why Arrowhead Pharmaceuticals Skyrocketed Almost 30% in ... - Nasdaq

What happened Arrowhead Pharmaceuticals (NASDAQ: ARWR) jumped 29.9% in September, according to data from S&P Global Market Intelligence . This. read more